Physician

Khalid Ali Kambal, M.B,B.CH

According to 2025 Medicare claims, Khalid Kambal, M.B, B.CH (NPI: 1063513224) practices medical oncology in the Minneapolis-St. Paul-Bloomington, MN-WI market, with the plurality of this provider's patient population coming from Carver, MN. This provider's primary affiliated billing organization is MINNESOTA ONCOLOGY HEMATOLOGY, PA (NPI: 1528035995; TIN: 411793418) and primary practice location at 55387-1753. Kambal is affiliated with the Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Kambal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 235 traditional Medicare patients, billed 46,569 HCPCS/CPT codes, and received $971,850 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 410 prescription claims across 102 beneficiaries totaling $416,564 in drug costs, led by Lenalidomide (Lenalidomide). 2018 DME data shows 23 claims. Open Payments data shows 1 records totaling $16. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $18,990 to $971,850. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	111	260	$18,990
2016	89	201	$12,704
2017	81	172	$10,732
2018	62	108	$5,390
2019	87	165	$9,301
2020	78	168	$9,122
2021	76	192	$13,000
2022	89	263	$15,778
2023	182	27,906	$354,505
2024	235	46,569	$971,850

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	129	690	$621,592
2016	113	601	$557,148
2017	105	595	$726,673
2018	104	561	$803,136
2019	112	617	$1,600,664
2020	109	742	$2,428,244
2021	109	729	$2,112,439
2022	143	813	$1,382,504
2023	168	622	$1,147,850
2024	102	410	$416,564

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	14	$24,825
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	23	$2,281
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	50	50	$169
96413	Administration of chemotherapy into vein, 1 hour or less	51	121	$102
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	43	62	$95
36415	Insertion of needle into vein for collection of blood sample	44	97	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	48	99	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lenalidomide	Lenalidomide	14	359	$160,586
Creon	Lipase/Protease/Amylase	11	301	$16,314
Eliquis	Apixaban	27	780	$15,478
Letrozole	Letrozole	46	3,181	$862
Dexamethasone	Dexamethasone	29	386	$457

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$16	E.R. Squibb & Sons, L.L.C.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Khalid Ali Kambal, M.B, B.CH?

Tedicare shows public-source Medicare data for Khalid Ali Kambal, M.B, B.CH (NPI 1063513224), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Khalid Ali Kambal, M.B, B.CH have ACO affiliation data?

Khalid Ali Kambal, M.B, B.CH is shown with ACO affiliation data for Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Khalid Ali Kambal, M.B, B.CH?

Khalid Ali Kambal, M.B, B.CH is linked to MINNESOTA ONCOLOGY HEMATOLOGY, PA (billing NPI 1528035995) in the available physician profile data.

Does Khalid Ali Kambal, M.B, B.CH have Open Payments data?

Khalid Ali Kambal, M.B, B.CH has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.